KS

Kiran Singh

Active Director Director DIN 02459431
DIN 02459431 First appointment Dec 2008 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2008
Shareholding value Locked Premium profile

About Kiran Singh

Kiran Singh has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Eugenics Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02459431
Primary Designation Director
First Appointment 18 Dec 2008
Oldest Company Age 17 yrs

Current companies

Company Designation Appointment Founded Status
Eugenics Pharma Private Limited U85100WB2008PTC129242
Director 18 Dec 2008 2008 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eugenics Pharma Private Limited
Premium access

Shareholding and investment profile for Kiran Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Singh

Kiran Singh has 17 years in corporate governance. Holds Director role. Currently with 1 company, including Eugenics Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Kiran Singh is associated with 1 company as Director.

Kiran Singh has expertise in General Business.

Kiran Singh has 17 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available